Detalhe da pesquisa
1.
Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors.
Oncologist
; 23(11): 1388-1390, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30012876
2.
Application of PCR-LDR-nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine.
J Med Virol
; 82(7): 1143-9, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20513076
3.
Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer.
Adv Ther
; 36(8): 2122-2136, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31140124
4.
Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data Set.
JCO Clin Cancer Inform
; 3: 1-13, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31403818
5.
Development and Validation of a High-Quality Composite Real-World Mortality Endpoint.
Health Serv Res
; 53(6): 4460-4476, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756355
6.
Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan.
PLoS One
; 12(3): e0172942, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28249005
7.
Author's Response to "A Letter in Support of Real-World RECIST".
Adv Ther
; 37(4): 1691-1693, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32056085
8.
Point-of-care diagnostic tests for low-resource settings.
Lancet Glob Health
; 3(5): e257-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25889467